IN CASE YOU MISSED IT: The Washington Examiner published the below op-ed on Friday by Charles Duan, Director of Technology and Innovation Policy at the R Street Institute, examining many ways the STRONGER Patents Act would be disastrous for the patent system, enabling Big Pharma to expand their rampant patent abuse, and for American patients, who will […]

Continue Reading

IN CASE YOU MISSED IT: CNN published the op-ed below today by Lincoln Network co-founder, Garrett Johnson and Innovation Defense Foundation president, Wayne Brough highlighting the importance of inter partes review (IPR) for canceling invalid patents which are a significant cause of the drug pricing crisis facing American patients. This op-ed echoes what CAPA has told lawmakers, that IPR is essential […]

Continue Reading

Coalition organizes letter to Senators Coons and Tillis expressing significant concern that the STRONGER Patents Act would embolden Big Pharma to continue abusing the patent system and continue raising prices on prescription drugs WASHINGTON, D.C. –  Ahead of today’s Senate Judiciary Subcommittee hearing on the STRONGER Patents Act of 2019, over 20 organizations from across […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Alex Moss with the Electronic Frontier Foundation posted a must-read rebuke of Sen. Coons’ STRONGER Patents Act. Moss’ piece details how this legislation would gut the inter partes review process – an internal process available to the Patent and Trademark Office that saves time and considerable costs […]

Continue Reading